Role of circular RNA in neurological disease

Role of circular RNA in neurological disease

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Dades bibliogràfiques
Autor principal:	Salsabil, Labiba
Altres autors:	Chowdhury, Namara Mariam
Format:	Thesis
Idioma:	English
Publicat:	Brac University 2024
Matèries:	Circular RNA circRNA Neurological disorder Alzheimer’s disease Parkinson’s disease Nervous system > Diseases. Molecular neurobiology.
Accés en línia:	http://hdl.handle.net/10361/23932

Ítems similars

Investigating the link between Cardiovascular diseases and neurodegenerative disorders
per: Dey, Manashi
Publicat: (2024)

Application of microRNA (miRNA) in Alzheimer’s Disease (AD)
per: Halim, Rabea
Publicat: (2022)

Potential treatments for epigenetic dysregulation in neurological diseases
per: Zaman, Rubaiyat
Publicat: (2024)

Targeting circular RNA for cardiovascular diseases
per: Sarkar, Deepannita
Publicat: (2023)

A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
per: Bakar, Osama Bin Abu
Publicat: (2024)

RNA drugs and RNA targets for small molecules: Prospects and challenges
per: Islam, Md. Raihanul
Publicat: (2024)

Implications of unusual non-coding RNAs in human diseases
per: Ahmed, Tazkia
Publicat: (2021)

Epigenetic dysregulation in neurodegenerative diseases and potential treatment
per: Mostofa, Golam
Publicat: (2022)

Knowledge of Alzheimer’s disease and its relationship with attitude towards genetic testing for the disease: a survey of the general public in Bangladesh
per: Chowdhury, Sariya Uzrat
Publicat: (2022)

A review on optogenetics and its potential in neurological disorder management
per: Armin, Fariza
Publicat: (2024)

A computational approach to design putative potential siRNAs for silencing the nucleoprotein and surface glycoprotein gene of MARV
per: Suraiya, Tasnia Iffat
Publicat: (2023)

Gene editing for neurodegenerative diseases-A review
per: Sharna, Anika Islam
Publicat: (2023)

Diagnostic biomarkers of Parkinson’s disease: The present and the future
per: Ferdous, Labiba
Publicat: (2023)

Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
per: Alim, Abdul
Publicat: (2023)

Impact of Lifestyle on the Disease Progression of Parkinson’s
per: Annee, Israt Jahan
Publicat: (2023)

Glymphatic system: a pathway for managing endogenous metabolites in CNS
per: Tasneem, Sadia
Publicat: (2021)

A review paper on developing novel antiviral strategies against pathogenic RNA viruses
per: Nawar, Numia
Publicat: (2021)

Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
per: Tabassum, Nadira
Publicat: (2024)

Parkinson’s disease and COVID-19: treatment and patient management during a pandemic
per: Afsana, Nourin
Publicat: (2022)

Role of protein’s and future treatment options for Alzheimer’s Disease
per: Islam, Md. Irfath
Publicat: (2023)

Unlocking the therapeutic potential of RNA: a comprehensive review of RNA-based therapy
per: Ahmad, Rafid Uddin, et al.
Publicat: (2024)

Role of voltage-gated sodium channel modulators in peripheral nervous system disorders
per: Mithila, Sabekun Nahar
Publicat: (2023)

A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
per: Shehab, Habibul Mohsin
Publicat: (2024)

A review on RNAi technology and its therapeutic potential in Cancer
per: Mahaleka, Aarshi
Publicat: (2024)

Biomarkers of Alzheimer’s disease: a hope for early diagnosis
per: Aziz, Farhin
Publicat: (2019)

A look into parkinson’s disease and the implications of gene therapy as a novel clinical approach
per: Islam, Md. Rakibul
Publicat: (2023)

Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
per: Karmaker, Swastika
Publicat: (2024)

Therapeutic implication of senescent cell elimination in neurodegenerative diseases
per: Key, Nasrin Sultana
Publicat: (2023)

Cerebrovascular and neurological dysfunction as a result of COVID-19 infection in patients with migraine
per: Rawshan, A. E. Maisha
Publicat: (2022)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
per: Ishrat, Nowshin
Publicat: (2024)

Review on: Contribution of nutrients to retard the progression of Alzheimer’s disease
per: Saha, Bithi Rani
Publicat: (2023)

Parkinson's disease in Bangladesh: An evaluation of the public knowledge and awareness
per: Chowdhury, Amal
Publicat: (2024)

Treatment options of Parkinson’s disease: How far we are from the cure?
per: Afreen, Nuraia
Publicat: (2021)

Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
per: Hassan, Md. Muhtaz
Publicat: (2020)

A review on the role of Myc and miRNA in Glioblastoma multiforme
per: Naureen, Ishrat
Publicat: (2022)

Review on: the mechanism and function of Glia in parkinson's disease
per: Abedin, Khondokar Mezbahul
Publicat: (2023)

Alzheimer's disease and marriage : an intimate account /
per: Wright, Lore K.
Publicat: (1993)

Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
per: Tamanna, Mst. Taskia
Publicat: (2023)

In silico analysis revealed hsa-miR-19a-3p and hsa-miR-19b-3p as two potential inhibitors of EGF mRNA in Breast Cancer
per: Nuha, Nabiha Tahsin
Publicat: (2024)

Detection of Parkinson’s disease from Neuro-imagery using deep neural network with transfer learning
per: Asaduzzaman, et al.
Publicat: (2021)